Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma

Eric A. Engels, Dana E. Rollison, Patricia Hartge, Dalsu Baris, James R Cerhan, Richard K. Severson, Wendy Cozen, Scott Davis, Robert J. Biggar, James J. Goedert, Raphael P. Viscidi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Two related polyomaviruses, JC virus (JCV) and BK virus (BKV), commonly cause lifelong infections in humans, with periodic reactivation manifesting as viral shedding in urine. Because JCV can infect lymphocytes and cause chromosomal damage, it is a plausible candidate to cause non-Hodgkin lymphoma (NHL). To test this hypothesis, we measured IgG antibodies to JCV and BKV capsids using a virus-like particle enzyme immunoassay in 3 separate groups of subjects. First, in a U.S. population-based case-control study of NHL (724 cases, 622 controls), we found lower JCV antibody levels in cases than controls (median optical density = 0.12 vs. 0.21, p < 0.0001); likewise, JCV seroprevalence was lower in cases (49% vs. 59%, adjusted odds ratio [OR] = 0.70, 95% confidence interval [CI] = 0.56-0.87). In contrast, BKV antibody levels did not differ between groups. Second, we found that JCV and BKV antibody levels changed little over time among 24 NHL patients receiving chemotherapy. Third, we evaluated 126 homosexual men, of whom 46 were shedding JCV and 14 were shedding BKV in urine. Antibody levels were much higher in shedders than non-shedders (JCV: median optical density = 0.67 vs. 0.07, p < 0.0001; BKV: 0.87 vs. 0.40, p = 0.003), indicating that these antibodies are a marker for viral replication. Because no deficit of BKV antibody was seen in NHL cases, and because antibody levels did not change materially with chemotherapy, we suggest that the lower levels of JCV antibody observed in NHL patients may not be due entirely to a disease or treatment effect. Additional research is needed to determine whether JCV replication is decreased in individuals with NHL and whether these findings are consistent with an etiologic role for JCV in NHL.

Original languageEnglish (US)
Pages (from-to)1013-1019
Number of pages7
JournalInternational Journal of Cancer
Volume117
Issue number6
DOIs
StatePublished - Dec 20 2005

Fingerprint

BK Virus
JC Virus
Non-Hodgkin's Lymphoma
Antibodies
Urine
Virus Shedding
Drug Therapy
Polyomavirus
Capsid
Seroepidemiologic Studies
Virus Replication
Immunoenzyme Techniques
Virion
Case-Control Studies
Immunoglobulin G

Keywords

  • BK virus
  • Case-control study
  • Epidemiology
  • JC virus
  • Non-hodgkin lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Engels, E. A., Rollison, D. E., Hartge, P., Baris, D., Cerhan, J. R., Severson, R. K., ... Viscidi, R. P. (2005). Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. International Journal of Cancer, 117(6), 1013-1019. https://doi.org/10.1002/ijc.21277

Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. / Engels, Eric A.; Rollison, Dana E.; Hartge, Patricia; Baris, Dalsu; Cerhan, James R; Severson, Richard K.; Cozen, Wendy; Davis, Scott; Biggar, Robert J.; Goedert, James J.; Viscidi, Raphael P.

In: International Journal of Cancer, Vol. 117, No. 6, 20.12.2005, p. 1013-1019.

Research output: Contribution to journalArticle

Engels, EA, Rollison, DE, Hartge, P, Baris, D, Cerhan, JR, Severson, RK, Cozen, W, Davis, S, Biggar, RJ, Goedert, JJ & Viscidi, RP 2005, 'Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma', International Journal of Cancer, vol. 117, no. 6, pp. 1013-1019. https://doi.org/10.1002/ijc.21277
Engels, Eric A. ; Rollison, Dana E. ; Hartge, Patricia ; Baris, Dalsu ; Cerhan, James R ; Severson, Richard K. ; Cozen, Wendy ; Davis, Scott ; Biggar, Robert J. ; Goedert, James J. ; Viscidi, Raphael P. / Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. In: International Journal of Cancer. 2005 ; Vol. 117, No. 6. pp. 1013-1019.
@article{705817daadaf4de9b4231c3ffef7223e,
title = "Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma",
abstract = "Two related polyomaviruses, JC virus (JCV) and BK virus (BKV), commonly cause lifelong infections in humans, with periodic reactivation manifesting as viral shedding in urine. Because JCV can infect lymphocytes and cause chromosomal damage, it is a plausible candidate to cause non-Hodgkin lymphoma (NHL). To test this hypothesis, we measured IgG antibodies to JCV and BKV capsids using a virus-like particle enzyme immunoassay in 3 separate groups of subjects. First, in a U.S. population-based case-control study of NHL (724 cases, 622 controls), we found lower JCV antibody levels in cases than controls (median optical density = 0.12 vs. 0.21, p < 0.0001); likewise, JCV seroprevalence was lower in cases (49{\%} vs. 59{\%}, adjusted odds ratio [OR] = 0.70, 95{\%} confidence interval [CI] = 0.56-0.87). In contrast, BKV antibody levels did not differ between groups. Second, we found that JCV and BKV antibody levels changed little over time among 24 NHL patients receiving chemotherapy. Third, we evaluated 126 homosexual men, of whom 46 were shedding JCV and 14 were shedding BKV in urine. Antibody levels were much higher in shedders than non-shedders (JCV: median optical density = 0.67 vs. 0.07, p < 0.0001; BKV: 0.87 vs. 0.40, p = 0.003), indicating that these antibodies are a marker for viral replication. Because no deficit of BKV antibody was seen in NHL cases, and because antibody levels did not change materially with chemotherapy, we suggest that the lower levels of JCV antibody observed in NHL patients may not be due entirely to a disease or treatment effect. Additional research is needed to determine whether JCV replication is decreased in individuals with NHL and whether these findings are consistent with an etiologic role for JCV in NHL.",
keywords = "BK virus, Case-control study, Epidemiology, JC virus, Non-hodgkin lymphoma",
author = "Engels, {Eric A.} and Rollison, {Dana E.} and Patricia Hartge and Dalsu Baris and Cerhan, {James R} and Severson, {Richard K.} and Wendy Cozen and Scott Davis and Biggar, {Robert J.} and Goedert, {James J.} and Viscidi, {Raphael P.}",
year = "2005",
month = "12",
day = "20",
doi = "10.1002/ijc.21277",
language = "English (US)",
volume = "117",
pages = "1013--1019",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma

AU - Engels, Eric A.

AU - Rollison, Dana E.

AU - Hartge, Patricia

AU - Baris, Dalsu

AU - Cerhan, James R

AU - Severson, Richard K.

AU - Cozen, Wendy

AU - Davis, Scott

AU - Biggar, Robert J.

AU - Goedert, James J.

AU - Viscidi, Raphael P.

PY - 2005/12/20

Y1 - 2005/12/20

N2 - Two related polyomaviruses, JC virus (JCV) and BK virus (BKV), commonly cause lifelong infections in humans, with periodic reactivation manifesting as viral shedding in urine. Because JCV can infect lymphocytes and cause chromosomal damage, it is a plausible candidate to cause non-Hodgkin lymphoma (NHL). To test this hypothesis, we measured IgG antibodies to JCV and BKV capsids using a virus-like particle enzyme immunoassay in 3 separate groups of subjects. First, in a U.S. population-based case-control study of NHL (724 cases, 622 controls), we found lower JCV antibody levels in cases than controls (median optical density = 0.12 vs. 0.21, p < 0.0001); likewise, JCV seroprevalence was lower in cases (49% vs. 59%, adjusted odds ratio [OR] = 0.70, 95% confidence interval [CI] = 0.56-0.87). In contrast, BKV antibody levels did not differ between groups. Second, we found that JCV and BKV antibody levels changed little over time among 24 NHL patients receiving chemotherapy. Third, we evaluated 126 homosexual men, of whom 46 were shedding JCV and 14 were shedding BKV in urine. Antibody levels were much higher in shedders than non-shedders (JCV: median optical density = 0.67 vs. 0.07, p < 0.0001; BKV: 0.87 vs. 0.40, p = 0.003), indicating that these antibodies are a marker for viral replication. Because no deficit of BKV antibody was seen in NHL cases, and because antibody levels did not change materially with chemotherapy, we suggest that the lower levels of JCV antibody observed in NHL patients may not be due entirely to a disease or treatment effect. Additional research is needed to determine whether JCV replication is decreased in individuals with NHL and whether these findings are consistent with an etiologic role for JCV in NHL.

AB - Two related polyomaviruses, JC virus (JCV) and BK virus (BKV), commonly cause lifelong infections in humans, with periodic reactivation manifesting as viral shedding in urine. Because JCV can infect lymphocytes and cause chromosomal damage, it is a plausible candidate to cause non-Hodgkin lymphoma (NHL). To test this hypothesis, we measured IgG antibodies to JCV and BKV capsids using a virus-like particle enzyme immunoassay in 3 separate groups of subjects. First, in a U.S. population-based case-control study of NHL (724 cases, 622 controls), we found lower JCV antibody levels in cases than controls (median optical density = 0.12 vs. 0.21, p < 0.0001); likewise, JCV seroprevalence was lower in cases (49% vs. 59%, adjusted odds ratio [OR] = 0.70, 95% confidence interval [CI] = 0.56-0.87). In contrast, BKV antibody levels did not differ between groups. Second, we found that JCV and BKV antibody levels changed little over time among 24 NHL patients receiving chemotherapy. Third, we evaluated 126 homosexual men, of whom 46 were shedding JCV and 14 were shedding BKV in urine. Antibody levels were much higher in shedders than non-shedders (JCV: median optical density = 0.67 vs. 0.07, p < 0.0001; BKV: 0.87 vs. 0.40, p = 0.003), indicating that these antibodies are a marker for viral replication. Because no deficit of BKV antibody was seen in NHL cases, and because antibody levels did not change materially with chemotherapy, we suggest that the lower levels of JCV antibody observed in NHL patients may not be due entirely to a disease or treatment effect. Additional research is needed to determine whether JCV replication is decreased in individuals with NHL and whether these findings are consistent with an etiologic role for JCV in NHL.

KW - BK virus

KW - Case-control study

KW - Epidemiology

KW - JC virus

KW - Non-hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=28044446990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044446990&partnerID=8YFLogxK

U2 - 10.1002/ijc.21277

DO - 10.1002/ijc.21277

M3 - Article

C2 - 15986438

AN - SCOPUS:28044446990

VL - 117

SP - 1013

EP - 1019

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -